Serum crosslaps as marker of bone resorption in dialysis patients.

被引：0
|
作者：
Kamel, S
Meddah, B
Oprisiu-Fournier, R
Giorgita, A
Barsum, J
Villain, V
Morinière, P
Bouro, F
Fournier, A
Brazier, M
机构：
[1] CHU Amiens, Fac Pharm, Biochim Lab, Amiens, France
[2] CHU Amiens, Serv Nephrol, Amiens, France
[3] Cis Bio, Gif Sur Yvette, France
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 1999年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SA245
引用
收藏
页码：S370 / S370
页数：1
相关论文
共 50 条
  • [21] Parathyroid hormone: Another nutritional marker in dialysis patients.
    Rohatgi, R
    Heneghan, W
    Uribarri, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (04) : A29 - A29
  • [22] Low bone mineral density in dialysis patients.
    Stein, MS
    Packham, DK
    Ebeling, PR
    Wark, JD
    Becker, GJ
    [J]. KIDNEY INTERNATIONAL, 1996, 50 (04) : 1410 - 1410
  • [23] Early effect of nasal salmon calcitonin on the bone marker Crosslaps
    Demet Ofluoglu
    Evrim Karadag-Saygi
    Cuneyt Canbulat
    Osman Hakan Gunduz
    Evren KUL-Panza
    Gulseren Akyuz
    [J]. Rheumatology International, 2006, 26 : 288 - 291
  • [24] AN IMMUNOASSAY FOR THE MEASUREMENT OF FREE PYRIDINOLINE IN SERUM - A MARKER OF BONE-RESORPTION
    KUNG, VT
    GOMEZ, B
    LUNDGARD, R
    SEYEDIN, S
    CLARK, B
    RIGGS, L
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S151 - S151
  • [25] Tartrate-resistant acid phosphatase (TRAP) as a serum marker for bone resorption in breast cancer patients with bone metastases
    Tauchert, S.
    di Liberto, A.
    Cordes, T.
    Thill, M.
    Salehin, D.
    Friedrich, M.
    [J]. CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2009, 36 (04): : 219 - 225
  • [26] Clinic usefulness of urinary CrossLaps as a sensitive marker of bone metabolism
    Nakayama, H
    Yano, T
    Sagara, Y
    Ando, K
    Kasai, Y
    Taketani, Y
    [J]. ENDOCRINE JOURNAL, 1997, 44 (04) : 479 - 484
  • [27] Acute effects in healthy women of oral calcium on the calcium-parathyroid axis and bone resorption as assessed by serum β-CrossLaps
    Zikán, V
    Haas, T
    Stepan, JJ
    [J]. CALCIFIED TISSUE INTERNATIONAL, 2001, 68 (06) : 352 - 357
  • [28] Early effect of nasal salmon calcitonin on the bone marker Crosslaps
    Ofluoglu, D
    Karadag-Saygi, E
    Canbulat, C
    Gunduz, OH
    KUL-Panza, E
    Akyuz, G
    [J]. RHEUMATOLOGY INTERNATIONAL, 2006, 26 (04) : 288 - 291
  • [29] Performance of b-Crosslaps serum on the Elecsys 2010 in comparison with six serum and urine bone resorption markers in microtiter assay format.
    Leary, ET
    McLaughlin, MK
    Swezey, D
    Foster, AP
    [J]. CLINICAL CHEMISTRY, 2000, 46 (06) : A145 - A145
  • [30] Circulating and bone levels of sclerostin in CKD and dialysis patients.
    Albrecht, Lauren
    Pereira, Renata
    Salusky, Isidro
    Laster, Marciana
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2022, 37 : 127 - 128
12345